Science · Breakthroughs · The National News · 2026-10-04T00:00:00.000Z
Researchers in the UAE have leveraged artificial intelligence to discover a new class of potential blood cancer drugs, known as PROTACs. These molecules are designed to target and destroy specific proteins that promote malignant cell growth in certain leukemias and lymphomas. This AI-driven approach, detailed in the Journal of Medicinal Chemistry, represents a significant advancement in accelerating drug development timelines and offers a promising new avenue for cancer therapy.
Read original source
Science · Computing · Bioengineer.org · 2026-10-04T00:00:00.000Z
Researchers in India have developed an AI system, combining convolutional neural networks and vision transformers, to classify colorectal histopathology images with 96.27% accuracy. This significant advancement in automated pathology could alleviate diagnostic burdens for one of the deadliest cancers, potentially speeding up and improving early detection.
Read original source
Science · Biology · Bioengineer.org · 2026-10-04T00:00:00.000Z
A new bioinformatics study in Stress Biology reveals that tardigrades, known for extreme resilience, exhibit convergent evolution in proteins that enable survival under desiccation, temperature extremes, and radiation. This research offers insights into the molecular mechanisms of stress tolerance, highlighting how different species independently develop similar solutions to environmental challenges.
Read original source
Science · Biology · Scienmag · 2026-10-04T00:00:00.000Z
A study in Cellular and Molecular Life Sciences identified Claudin-1 (CLDN1) as a key protein enabling prostate cancer cells to resist chemotherapy. CLDN1 facilitates neuroendocrine transdifferentiation, a process where cancer cells become treatment-resistant. Depleting CLDN1 in models reduced this shift and resistance to docetaxel, offering a potential new therapeutic target.
Read original source
